Success Stories: NIW Approval Won for a Research Fellow in Biomedical Science from China with Help from Our Experts at North America Immigration Law Group

 

On March 21st, 2022, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Biomedical Science (Approval Notice).


General Field: Biomedical Science

Position at the Time of Case Filing: Research Fellow

Country of Origin: China

Country of Residence at the Time of Filing: Canada

Approval Notice Date: March 21st, 2022

Processing Time: 3 months, 18 days


Case Summary:

It is well-known that one of the certain ways to determine the worth of a researcher is to look at the funding they have received. This is how we knew our client from China, a research fellow in biomedical science, was the perfect fit for the National Interest Waiver (NIW) category. As an expert in the field of biomedical science, he had received 4 major funding from national and international institutions namely the National Institute of Diabetes and Digestive and Kidney Diseases, the Canadian Institutes of Health Research, the Natural Sciences and Engineering Research Council of Canada, the Cancer Research Society.

His proposed endeavor was to continue his research investigating the molecular mechanisms behind genetic disorders, inflammation-associated disorders, and cancers in order to facilitate the development of novel treatments. It was evident that his work is of great importance because it deepens understanding and provides novel treatment avenues for genetic disorders, inflammation-associated disorders, and cancers. It was due to this that one of his 4 recommenders had the following to say:

“The real-world significance of [the client’s] research is further evident in its applicability to numerous degenerative disorders that involve telomere damage and many genetic blood disorders. ln view of these essential contributions to the field's ability to combat a variety of incurable conditions, [the client] has become an indispensable asset to biomedical science research, and it is abundantly evident that he is well-positioned to remain at the leading edge of discovery in his field.”

His work in the area has resulted in 4 peer-reviewed journal articles (3 of them first-authored) and 1 first-authored book chapter, and these publications have been cited a total of 130 times according to Google Scholar.

In the petition letter, we presented detailed descriptions of 3 of his key projects as evidence of his contributions to and expertise in the field of biomedical science. These project summaries were complemented by expert commentaries that highlighted his use of innovative methodologies, the nature of his breakthroughs, and the ways that his unique findings have been applied throughout the field. Our client has pursued research directly related to his proposed endeavor of investigating the molecular mechanisms behind genetic disorders, inflammation-associated disorders, and cancers for 8 years.

Thus his education, experience, expertise, record of publication and citation, and history of successful research in the field all helped indicate that he is well positioned to advance the proposed endeavor. These facts established that it is beneficial to the United States to waive the requirements of a job offer and labor certification. So, when he received his approval just after 108 days of deliberation, we were happy to share in his success. We wish him the very best in all his future endeavors.